Diethylstilbestrol-Induced Estrogen Receptor-Dependent [Ca²⁺]_i Rises and Apoptosis in Chinese Hamster Ovary (CHO) Cells

REFERENCES

• Newbold R R, Padilla-Banks E, Jefferson W N. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006; 147: S11–S17
   PubMed Web of Science ®Google Scholar
• Rubin M M. Antenatal exposure to DES: Lessons learned…future concerns. Obstet Gynecol Surv 2007; 62: 548–555
   PubMedGoogle Scholar
• Tayama S, Nakagawa Y, Tayama K. Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. Mutat Res Aug 19, 2007, [Epub ahead of print]
   Google Scholar
• Kaitsuka T, Fukunaga K, Soeda F, Shirasaki T, Miyamoto E, Takahama K. Changes in Ca2+/calmodulin-dependent protein kinase II activity and its relation to performance in passive avoidance response and long-term potentiation formation in mice prenatally exposed to diethylstilbestrol. Neuroscience 2007; 144: 1415–1424
   PubMed Web of Science ®Google Scholar
• Li X, Zhang S, Safe S. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds. J Steroid Biochem Mol Biol 2006; 98: 122–132
   PubMedGoogle Scholar
• Lobaton C D, Vay L, Hernandez-Sanmiguel E, Santodomingo J, Moreno A, Montero M, Alvarez J. Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005; 145: 862–871
   PubMed Web of Science ®Google Scholar
• Samadi A, Cenedella R J, Carlson C G. Diethylstilbestrol increases intracellular calcium in lens epithelial cells. Pflugers Arch 2005; 450: 145–154
   Google Scholar
• Huang J K, Jan C R. Mechanism of estrogens-induced increases in intracellular Ca2+ in PC3 human prostate cancer cells. Prostate 2001; 47: 141–148
   Google Scholar
• Chang H T, Hsu S S, Chen J S, Lin K L, Wang J L, Cheng H H, Lu Y C, Jiann B P, Liu C P, Huang J K, Yeh J H, Chiang A J, Chen W C, Jan C R. Effect of diethylstilbestrol on Ca2+ handling and cell viability in human breast cancer cells. Chin J Physiol 2003; 46: 187–192
   Google Scholar
• Chen Y C, Chen S J, Chang H T, Huang J K, Wang J L, Tseng L L, Chang H J, Su W, Law Y P, Chen W C, Jan C R. Mechanisms of diethylstilbestrol-induced calcium movement in MG63 human osteosarcoma cells. Toxicol Lett 2001; 122: 245–253
   Google Scholar
• Zakharov S I, Smani T, Dobrydneva Y, Monje F, Fichandler C, Blackmore P F, Bolotina V M. Diethylstilbestrol is a potent inhibitor of store-operated channels and capacitative Ca2+ influx. Mol Pharmacol 2004; 66: 702–707
   PubMed Web of Science ®Google Scholar
• Dobrydneva Y, Williams R L, Katzenellenbogen J A, Ratz P H, Blackmore P F. Diethylstilbestrol and tetrahydrochrysenes are calcium channel blockers in human platelets: relationship to the stilbene pharmacophore. Thromb Res 2003; 110: 23–31
   PubMed Web of Science ®Google Scholar
• Derfoul A, Lin F J, Awumey E M, Kolodzeski T, Hall D J, Tuan R S. Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem 2003; 89: 755–770
   PubMed Web of Science ®Google Scholar
• Khan S Z, Kirk C J, Michelangeli F. Alkylphenol endocrine disrupters inhibit IP3-sensitive Ca2+ channels. Biochem Biophys Res Commun 2003; 310: 261–266
   Google Scholar
• Oda T, Tanaka M, Sasaki T. Cytotoxicity of synthetic estrogen and related compounds in various tumor-derived cells. Biol Pharm Bull 2001; 24: 1142–1144
   Google Scholar
• Konac E, Ekmekci A, Barkar V, Yilmaz A, Erbas D. Effects of diethylstilbestrol in human lymphocytes in vitro: a dose and time-dependent study on genotoxic, cytotoxic and apoptotic effects. Mol Cell Biochem 2005; 276: 45–53
   Google Scholar
• Robertson C N, Roberson K M, Padilla G M, O'Brien E T, Cook J M, Kim C S, Fine R L. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 1996; 88: 908–917
   PubMed Web of Science ®Google Scholar
• Kawanabe Y, Okamoto Y, Enoki T, Hashimoto N, Masaki T. Ca2+ channels activated by endothelin-1 in CHO cells expressing endothelin-A or endothelin-B receptors. Am J Physiol Cell Physiol 2001; 281: C1676–C1685
   Google Scholar
• Berridge M J. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315–325
   PubMed Web of Science ®Google Scholar
• Berridge M J. Elementary and global aspects of calcium signalling. J Physiol 1997; 499: 291–306
   PubMed Web of Science ®Google Scholar
• Bootman M D, Berridge M J, Roderick H L. Calcium signalling: More messengers, more channels, more complexity. Curr Biol 2002; 12: R563–R565
   PubMed Web of Science ®Google Scholar
• Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo G F. Apoptosis induced in neuronal cells by oxidative stress: Role played by caspases and intracellular calcium ions. Toxicol Lett 2003; 139: 125–133
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–3450
   PubMed Web of Science ®Google Scholar
• Cheng J S, Huang C C, Chou C T, Jan C R. Mechanisms of carvedilol-induced [Ca2+]i rises and death in human hepatoma cells. Naunyn Schmiedebergs Arch Pharmacol 2007; 376: 185–194
   Google Scholar
• Liu S I, Huang C C, Huang C J, Wang B W, Chang P M, Fang Y C, Chen W C, Wang J L, Lu Y C, Chu S T, Chou C T, Jan C R. Thimerosal-induced apoptosis in human SCM1 gastric cancer cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation. Toxicol Sci 2007; 100: 109–117
   PubMed Web of Science ®Google Scholar
• Hsu S S, Huang C J, Cheng H H, Chou C T, Lee H Y, Wang J L, Chen I S, Liu S I, Lu Y C, Chang H T, Huang J K, Chen J S, Jan C R. Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology 2007; 231: 21–29
   PubMed Web of Science ®Google Scholar
• Thastrup O, Cullen P J, Drobak B K, Hanley M R, Dawson A P. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 1990; 87: 2466–2470
   PubMed Web of Science ®Google Scholar
• Thompson A K, Mostafapour S P, Denlinger L C, Bleasdale J E, Fisher S K. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991; 266: 23856–23862
   PubMed Web of Science ®Google Scholar
• Florenzano F, Viscomi M T, Cavaliere F, Volonte C, Molinari M. The role of ionotropic purinergic receptors (P2X) in mediating plasticity responses in the central nervous system. Adv Exp Med Biol 2006; 557: 77–100
   PubMedGoogle Scholar
• Tsien R Y. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 1980; 19: 2396–3404
   PubMed Web of Science ®Google Scholar
• Huynh H T, Pollak M. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 1993; 53: 5585–5588
   Google Scholar
• Shukuwa K, Izumi S, Hishikawa Y, Ejima K, Inoue S, Muramatsu M, Ouchi Y, Kitaoka T, Koji T. Diethylstilbestrol increases the density of prolactin cells in male mouse pituitary by inducing proliferation of prolactin cells and transdifferentiation of gonadotropic cells. Histochem Cell Biol 2006; 126: 111–123
   Google Scholar
• Du Mond J W, Jr, Singh K P, Roy D. The biphasic stimulation of proliferation of Leydig cells by estrogen exposure. Int J Oncol 2001; 18: 623–628
   Google Scholar
• Geisler J, Haynes B, Anker G, Helle H, Ekse D, Dowsett M, Lning P E. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients. J Steroid Biochem Mol Biol 2005; 96: 415–422
   PubMedGoogle Scholar
• Kemp H A, Read G F, Riad-Fahmy D, Pike A W, Gaskell S J, Queen K, Harper M E, Griffiths K. Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate. Cancer Res 1981; 41: 4693–4697
   PubMed Web of Science ®Google Scholar
• Watson C S, Bulayeva N N, Wozniak A L, Alyea R A. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007; 72: 124–134
   PubMed Web of Science ®Google Scholar